Search Results - "Naik, Karan"

Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors by Reeser, Julie W., Martin, Dorrelyn, Miya, Jharna, Kautto, Esko A., Lyon, Ezra, Zhu, Eliot, Wing, Michele R., Smith, Amy, Reeder, Matthew, Samorodnitsky, Eric, Parks, Hannah, Naik, Karan R., Gozgit, Joseph, Nowacki, Nicholas, Davies, Kurtis D., Varella-Garcia, Marileila, Yu, Lianbo, Freud, Aharon G., Coleman, Joshua, Aisner, Dara L., Roychowdhury, Sameek

“…Kinase gene fusions are important drivers of oncogenic transformation and can be inhibited with targeted therapies. Clinical grade diagnostics using RNA…”
Get full text

CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer by Bange, Erin M., Han, Nicholas A., Wileyto, Paul, Kim, Justin Y., Gouma, Sigrid, Robinson, James, Greenplate, Allison R., Hwee, Madeline A., Porterfield, Florence, Owoyemi, Olutosin, Naik, Karan, Zheng, Cathy, Galantino, Michael, Weisman, Ariel R., Ittner, Caroline A. G., Kugler, Emily M., Baxter, Amy E., Oniyide, Olutwatosin, Agyekum, Roseline S., Dunn, Thomas G., Jones, Tiffanie K., Giannini, Heather M., Weirick, Madison E., McAllister, Christopher M., Babady, N. Esther, Kumar, Anita, Widman, Adam J., DeWolf, Susan, Boutemine, Sawsan R., Roberts, Charlotte, Budzik, Krista R., Tollett, Susan, Wright, Carla, Perloff, Tara, Sun, Lova, Mathew, Divij, Giles, Josephine R., Oldridge, Derek A., Wu, Jennifer E., Alanio, Cécile, Adamski, Sharon, Garfall, Alfred L., Vella, Laura A., Kerr, Samuel J., Cohen, Justine V., Oyer, Randall A., Massa, Ryan, Maillard, Ivan P., Maxwell, Kara N., Reilly, John P., Maslak, Peter G., Vonderheide, Robert H., Wolchok, Jedd D., Hensley, Scott E., Wherry, E. John, Meyer, Nuala J., DeMichele, Angela M., Vardhana, Santosha A., Mamtani, Ronac, Huang, Alexander C.

“…Patients with cancer have high mortality from coronavirus disease 2019 (COVID-19), and the immune parameters that dictate clinical outcomes remain unknown. In…”
Get full text

CD8.sup.+ T cells contribute to survival in patients with COVID-19 and hematologic cancer by Bange, Erin M, Han, Nicholas A, Wileyto, Paul, Kim, Justin Y, Gouma, Sigrid, Robinson, James, Greenplate, Allison R, Hwee, Madeline A, Porterfield, Florence, Owoyemi, Olutusin, Naik, Karan, Zheng, Cathy, Galantino, Michael, Weisman, Ariel R, Ittner, Caroline A.G, Kugler, Emily M, Baxter, Amy E

“…Patients with cancer have high mortality from coronavirus disease 2019 (COVID-19), and the immune parameters that dictate clinical outcomes remain unknown. In…”
Get full text

CD8+ T cells contribute to survival in COVID-19 patients with hematologic cancers by Bange, Erin M., Han, Nicholas A., Wileyto, Paul, Kim, Justin Y., Gouma, Sigrid, Robinson, James, Greenplate, Allison R., Hwee, Madeline A., Porterfield, Florence, Owoyemi, Olutosin, Naik, Karan, Zheng, Cathy, Galantino, Michael, Weisman, Ariel R., Ittner, Caroline A.G., Kugler, Emily M., Baxter, Amy E., Oniyide, Olutwatosin, Agyekum, Roseline S., Dunn, Thomas G., Jones, Tiffanie K., Giannini, Heather M., Weirick, Madison E., McAllister, Christopher M., Babady, N. Esther, Kumar, Anita, Widman, Adam J., DeWolf, Susan, Boutemine, Sawsan R., Roberts, Charlotte, Budzik, Krista R, Tollett, Susan, Wright, Carla, Perloff, Tara, Sun, Lova, Mathew, Divij, Giles, Josephine R., Oldridge, Derek A., Wu, Jennifer E., Alanio, Cécile, Adamski, Sharon, Garfall, Alfred L., Vella, Laura A, Kerr, Samuel J., Cohen, Justine V., Oyer, Randall A., Massa, Ryan, Maillard, Ivan P., Maxwell, Kara N., Reilly, John P., Maslak, Peter G., Vonderheide, Robert H., Wolchok, Jedd D., Hensley, Scott E., Wherry, E. John, Meyer, Nuala J., DeMichele, Angela M., Vardhana, Santosha A., Mamtani, Ronac, Huang, Alexander C.

“…Cancer patients have high mortality from COVID-19, and the immune parameters that dictate clinical outcomes remain unknown. In a cohort of 100 cancer patients…”
Get full text

Analysis of Quality of Services (QOS) on converged architecture by Malhan, P., Shrote, N., Naik, K., Mathur, P.

“…In this paper, we present The Converged Architecture and various services which are running on it along with the understanding of their characteristics…”
Get full text